Holen Sie sich die Stockscreener-App
14.66
0.54%
-0.08
Handel nachbörslich:
14.66
Indivior Plc Aktie (INDV) Neueste Nachrichten
Indivior PLC Announces Changes in Major Holdings - TipRanks
Wirral Council v Indivior/Reckitt: Supreme Court refuses permission to appeal representative action strike out - stewartslaw.com
Indivior PLC Corrects Director Shareholding Disclosure - TipRanks
REGIndivior PLCDirector/PDMR ShareholdingCorrection - TradingView
Naloxone Market to Reflect Significant Incremental - openPR.com
Indivior Directors Increase Stake in Company Shares - TipRanks
Suboxone Market Set to Witness Growth as Opioid Dependency - openPR.com
Substance Abuse Treatment Market Size, Trends & Growth - openPR.com
Indivior PLC Announces Changes in Major Shareholdings - MSN
Indivior-Funded Study Suggests Opvee Outperforms Narcan. But at What? - Filter
INDV DEADLINE ALERT: Bernstein Liebhard LLP Reminds Indivior PLC Investors of Upcoming Deadline - ACCESS Newswire
Indivior PLC (INDV) Stock Analysis: Exploring a 9.21% Potential Upside Amidst Strategic Developments - DirectorsTalk Interviews
Suboxone Market Is Booming Nationwide with New Formulations - openPR.com
Shareholders that lost money on Indivior PLC(INDV) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More - ACCESS Newswire
Indivior PLC Announces Change in Major Shareholder Holdings - TipRanks
Levi & Korsinsky Notifies Shareholders of Indivior PLC(INDV) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Substance Abuse Treatment Market Set to Witness Digital and Personalized Care Expansion | Indivior, Alkermes - openPR.com
Addex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference - GlobeNewswire Inc.
Indivior to delist from London Stock Exchange, maintain primary listing on Nasdaq - MSN
Indivior PLC (INDV) Stock Analysis: Evaluating the 17.71% Potential Upside Amidst Market Challenges - DirectorsTalk Interviews
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Indivior PLC To Contact The Firm - ACCESS Newswire
Indivior’s exit comes as no surprise - The Times
Levi & Korsinsky Notifies Indivior PLC Investors of a Class Action Lawsuit and Upcoming DeadlineINDV - ACCESS Newswire
Indivior PLC (INDV) Stock Price Down 3.27% on Jun 2 - GuruFocus
Opioid Use Disorder Market Projected to Witness Massive GrowthIndivior PLC, Alkermes plc - openPR.com
Trending tickers: The latest investor updates on Tesla, Palantir, Sanofi, Babcock and Indivior - Yahoo
Kalkine : Indivior’s Exit from London Exchange Impacts FTSE 100 Pharmaceutical Landscape - Kalkine Media
Indivior to delist from London Stock Exchangewill stay on Nasdaq - Insider Media Ltd
Drug maker Indivior joins London Stock Exchange exodus, 2 Jun 2025 11:00 - Shares Magazine
Kalkine : Indivior’s FTSE 100 Sector Shift: Delisting from London to Focus on Nasdaq Listing - Kalkine Media
Kalkine: Indivior Exits London as FTSE 100 Firm Focuses on Nasdaq - Kalkine Media
FTSE pharma giant joins London stock market exodus - The Telegraph
Indivior (INDV) Delists from London to Focus on U.S. Market - GuruFocus
Indivior brings curtain down on turbulent 11-year run in London - Proactive financial news
Indivior drops London listing to focus on U.S. market By Investing.com - Investing.com Nigeria
Indivior To Delist From LSE To Better Align With US Focused Business - Nasdaq
Indivior to cancel secondary listing in London - Sharecast.com
Indivior Plans to Cancel London Listing After Moving Primary to US - Bloomberg.com
Drug maker Indivior to abandon London stock market for the US - Yahoo
Indivior Announces Intention to Cancel Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained - GuruFocus
kalkine: FTSE 350 firm Indivior PLC (LON:INDV) to leave London listing after Nasdaq shift - Kalkine Media
Indivior to Cancel London Stock Exchange Listing, Focuses on Nasdaq - TipRanks
Indivior to Cancel Secondary Listing on London Stock Exchange, Maintains Primary Nasdaq Listing | Indivior Stock News - paginasiete.bo
Indivior to delist from London Stock Exchange, maintain Nasdaq listing - marketscreener.com
Indivior Announces Intention to Cancel Secondary Listing on Lond - GuruFocus
Indivior Announces Intention to Cancel Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained | INDV Stock News - GuruFocus
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 1, 2024 in Indivior PLC LawsuitINDV - ACCESS Newswire
Indivior Announces Patrick Barry as Chief Commercial Officer - The Malaysian Reserve
Indivior appoints Patrick Barry as Chief Commercial Officer By Investing.com - Investing.com South Africa
Indivior Announces Patrick Barry as Chief Commercial Officer | I - GuruFocus
Indivior appoints Patrick Barry as Chief Commercial Officer - Investing.com India
Indivior Announces Patrick Barry as Chief Commercial Officer | INDV Stock News - GuruFocus
1.05%
0.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):